Michelle Teng Email

Chief Scientific Officer, Executive Director and Co-Founder . SynaptixBio Ltd.

Oxford , Oxfordshire

Location

LinkedIn

Current Roles

Employees:
4
Revenue:
$310k
About
Overview\nSynaptixBio is a rare disease biotech company that is pioneering ground-breaking treatments for severe leukodystrophies and other childhood neurodegenerative diseases.\n  \nSynaptixBio’s mission is to deliver gene therapies for fatal leukodystrophies in children caused by loss of function or mutation in a single gene. Using a breadth of platforms including antisense oligonucleotide (ASO)-based technology, we can silence the expression of the toxic gene to reverse disease progression. This approach will create life saving treatments for severe genetic diseases that affect the central nervous system.
SynaptixBio Ltd. Address
9400 Garsington Road
Oxford , Oxfordshire
SynaptixBio Ltd. Email

#1 Startup Dataset

Growth rates, revenue data, direct competitors and contact details.